Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.

Ewing sarcoma is the second most common bone malignancy in children and young adults. It is driven by oncogenic fusion proteins (i.e. EWS/FLI1) acting as aberrant transcription factors that upregulate and downregulate target genes, leading to cellular transformation. Thus, identificating these targe...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Noelia Agra, Florencia Cidre, Laura García-García, Juan de la Parra, Javier Alonso
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2013
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/fc93598711a441c2ab01dba8774a1347
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!